Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes.
Increases in the expression of endothelin-1 (ET-1) in cardiac myocytes play a critical role in the development of heart failure in vivo. Whereas norepinephrine (NE) is a potent inducer of ET-1 expression in cardiac myocytes, the signaling pathways that link NE to inducible cardiac ET-1 expression are unknown. Adrenergic stimulation results in an increase in intracellular calcium levels, which in turn activates calcineurin. Here, we have shown that stimulation with NE markedly increased the expression of the ET-1 gene in primary cardiac myocytes from neonatal rats. This increase was severely attenuated by a beta-adrenergic antagonist, metoprolol, but not by an alpha-adrenergic antagonist, prazosin. Consistent with these data, the beta-adrenergic agonist isoproterenol (ISO) activated the rat ET-1 promoter activity to an extent that was similar to NE. The ISO-stimulated increase in promoter activity was significantly inhibited by a Ca(2+)-antagonist, nifedipine, and an immunosuppressant, cyclosporin A, which blocks calcineurin. Mutation analysis indicated that the GATA4 binding site is required for ISO-responsive ET-1 transcription. Stimulation with ISO enhanced the interaction between NFATc and GATA4 in cardiac myocytes. Consistent with this interaction, overexpression of GATA4 and NFATc synergistically activated the ET-1 promoter. These findings demonstrate that NE-stimulated ET-1 expression in cardiac myocytes is mediated predominantly via a beta-adrenergic pathway, and that calcium-activated calcineurin-GATA4 plays a role in this process.
Morimoto
T
T
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507 Japan.
Hasegawa
K
K
Wada
H
H
Kakita
T
T
Kaburagi
S
S
Yanazume
T
T
Sasayama
S
S
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D019703:Calcineurin / Q000502:physiology*; D016572:Cyclosporine / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000502:physiology*; D019332:Endothelin-1 / Q000235:genetics*; D050991:GATA4 Transcription Factor; D007545:Isoproterenol / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D050778:NFATC Transcription Factors; D009638:Norepinephrine / Q000494:pharmacology; D009687:Nuclear Proteins; D011401:Promoter Regions, Genetic; D051381:Rats; D017207:Rats, Sprague-Dawley; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology*; D014158:Transcription, Genetic
D000318:Adrenergic beta-Agonists; D004268:DNA-Binding Proteins; D019332:Endothelin-1; D050991:GATA4 Transcription Factor; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D011943:Receptors, Adrenergic, beta; D014157:Transcription Factors; D016572:Cyclosporine; D019703:Calcineurin; D007545:Isoproterenol; D009638:Norepinephrine